This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: National University of Singapore, Singapore Health Services Pte Ltd. Active years: 2023.
Company Filing History:
1 out of 850 
1 out of 140 
Years Active: 2023
Title: Innovations by Wei Wen Lim in Smooth Muscle Cell Dysfunction
Introduction
Wei Wen Lim is an accomplished inventor based in Singapore, known for his significant contributions to the field of medical science. He has developed a patent that addresses diseases associated with smooth muscle cell (SMC) dysfunction. His innovative approach focuses on the inhibition of IL-11-mediated signaling, providing new avenues for diagnosis, treatment, and prophylaxis.
Latest Patents
Wei Wen Lim holds a patent titled "Treatment of SMC mediated disease." This patent outlines methods for diagnosing and treating conditions linked to SMC dysfunction, showcasing his expertise in medical innovation. The patent emphasizes the importance of targeting IL-11 signaling pathways to improve patient outcomes.
Career Highlights
Throughout his career, Wei Wen Lim has worked with notable organizations, including Singapore Health Services Pte Ltd and the National University of Singapore. His roles in these institutions have allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Wei Wen Lim has collaborated with esteemed colleagues such as Stuart Alexander Cook and Sebastian Schaefer. These partnerships have further enriched his research and innovation efforts, leading to advancements in the understanding and treatment of SMC-related diseases.
Conclusion
Wei Wen Lim's work exemplifies the impact of innovative thinking in the medical field. His patent on SMC dysfunction treatment highlights the potential for new therapeutic strategies that can significantly benefit patients.